DS
Therapeutic Areas
Alcyomics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Skimune® for GvHD | Prediction of Graft-versus-Host Disease post-transplant | Validated/Clinical Use |
| Safety & Efficacy Testing Services | Broad immunotoxicity screening for client compounds | Commercial Service |
| Special Programmes | Custom assay development for novel modalities (e.g., ADCs, cell therapies) | Development/Service |